BACKGROUND: To identify associations of other cancers with hereditary prostate cancer (HPC) we estimated relative risks (RRs) of 36 different cancers in relatives of prostate cancer cases in the Utah Population Data Base (UPDB), which combines genealogical and cancer data for Utah. METHODS: We utilized known genetic relationships between prostate cancer cases and their relatives with cancer, combined with age- and sex-specific cancer rates calculated internally from the UPDB, to estimate RRs for cancer in relatives of prostate cancer cases. RESULTS: Multiple other cancers were observed in excess in both first- and second-degree relatives of HPC cases including colon cancer, non-Hodgkins lymphoma, multiple myeloma, rectal cancer, cancer of the gallbladder, and melanoma (skin). CONCLUSIONS: This analysis supports the existence of heritable prostate cancer syndromes that include other cancers. We hypothesize that the study of homogeneous pedigrees co-segregating prostate cancer and another cancer could allow more straightforward localization and identification of the gene(s) responsible. Copyright 2005 Wiley-Liss, Inc.
BACKGROUND: To identify associations of other cancers with hereditary prostate cancer (HPC) we estimated relative risks (RRs) of 36 different cancers in relatives of prostate cancer cases in the Utah Population Data Base (UPDB), which combines genealogical and cancer data for Utah. METHODS: We utilized known genetic relationships between prostate cancer cases and their relatives with cancer, combined with age- and sex-specific cancer rates calculated internally from the UPDB, to estimate RRs for cancer in relatives of prostate cancer cases. RESULTS: Multiple other cancers were observed in excess in both first- and second-degree relatives of HPC cases including colon cancer, non-Hodgkins lymphoma, multiple myeloma, rectal cancer, cancer of the gallbladder, and melanoma (skin). CONCLUSIONS: This analysis supports the existence of heritable prostate cancer syndromes that include other cancers. We hypothesize that the study of homogeneous pedigrees co-segregating prostate cancer and another cancer could allow more straightforward localization and identification of the gene(s) responsible. Copyright 2005 Wiley-Liss, Inc.
Authors: Phillip R Cooper; Barry B McGuire; Brian T Helfand; Stacy Loeb; Qiaoyan Hu; William J Catalona Journal: Urology Date: 2011-08-05 Impact factor: 2.649
Authors: Gudbjörg Jonsdottir; Sigrún H Lund; Magnus Björkholm; Ingemar Turesson; Malin Hultcrantz; Anna Porwit; Yogesh S Jethava; Ola Landgren; Sigurdur Y Kristinsson Journal: Blood Adv Date: 2017-11-22
Authors: Liesel M Fitzgerald; Shannon K McDonnell; Erin E Carlson; Wendy Langeberg; Laura M McIntosh; Kerry Deutsch; Elaine A Ostrander; Daniel J Schaid; Janet L Stanford Journal: Eur J Hum Genet Date: 2010-04-21 Impact factor: 4.246
Authors: Kevin B Jones; Joshua D Schiffman; Wendy Kohlmann; R Lor Randall; Stephen L Lessnick; Lisa A Cannon-Albright Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-01-17 Impact factor: 4.254
Authors: N Jewel Samadder; Ken Robert Smith; Jathine Wong; Heidi Hanson; Kenneth Boucher; Randall W Burt; Michael Charlton; Kathryn R Byrne; Juan F Gallegos-Orozco; Cathryn Koptiuch; Karen Curtin Journal: Dig Dis Sci Date: 2016-09-21 Impact factor: 3.199